LATS2 and acute myeloid leukemia: Knocking down of HOXA-AS2 can increase LATS2 promoter activity in AML cells (Fig. 4e), whereas overexpression of HOXA-AS2 can also decrease LATS2 promoter activity in AML cells (Fig. 4f).